Economic costs of nonmedical use of prescription opioids
- PMID: 21178601
- DOI: 10.1097/AJP.0b013e3181ff04ca
Economic costs of nonmedical use of prescription opioids
Abstract
Objectives: Although the economic costs of substance misuse have been extensively examined in the published literature, information on the costs of nonmedical use of prescription opioids is much more limited, despite being a significant and rapidly growing problem in the United States.
Methods: We estimated the current economic burden of nonmedical use of prescription opioids in the United States in terms of direct substance abuse treatment, medical complications, productivity loss, and criminal justice. We distributed our broad cost estimates among the various drugs of misuse, including prescription opioids, down to the individual drug level.
Results: In 2006, the estimated total cost in the United States of nonmedical use of prescription opioids was $53.4 billion, of which $42 billion (79%) was attributable to lost productivity, $8.2 billion (15%) to criminal justice costs, $2.2 billion (4%) to drug abuse treatment, and $944 million to medical complications (2%). Five drugs--OxyContin, oxycodone, hydrocodone, propoxyphene, and methadone--accounted for two-thirds of the total economic burden.
Discussion: The economic cost of nonmedical use of prescription opioids in the United States totals more than $50 billion annually; lost productivity and crime account for the vast majority (94%) of these costs.
Similar articles
-
Societal costs of prescription opioid abuse, dependence, and misuse in the United States.Pain Med. 2011 Apr;12(4):657-67. doi: 10.1111/j.1526-4637.2011.01075.x. Epub 2011 Mar 10. Pain Med. 2011. PMID: 21392250
-
Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective.Clin J Pain. 2006 Oct;22(8):667-76. doi: 10.1097/01.ajp.0000210915.80417.cf. Clin J Pain. 2006. PMID: 16988561
-
Economic burden of prescription opioid misuse and abuse.J Manag Care Pharm. 2009 Sep;15(7):556-62. doi: 10.18553/jmcp.2009.15.7.556. J Manag Care Pharm. 2009. PMID: 19739878 Free PMC article. Review.
-
The burden of the nonmedical use of prescription opioid analgesics.Pain Med. 2009 Jul;10 Suppl 2:S89-100. doi: 10.1111/j.1526-4637.2009.00668.x. Pain Med. 2009. PMID: 19691688 Review.
-
The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013.Med Care. 2016 Oct;54(10):901-6. doi: 10.1097/MLR.0000000000000625. Med Care. 2016. PMID: 27623005 Free PMC article.
Cited by
-
A Review of Federal and Statewide Guidelines and Their Effects on Orthopedics.Cureus. 2023 Sep 16;15(9):e45374. doi: 10.7759/cureus.45374. eCollection 2023 Sep. Cureus. 2023. PMID: 37849581 Free PMC article. Review.
-
Analisi di Budget Impact della formulazione depot di buprenorfina a rilascio prolungato per la gestione di pazienti affetti da disturbo da uso di oppiacei.Glob Reg Health Technol Assess. 2021 Jul 22;8:96-104. doi: 10.33393/grhta.2021.2237. eCollection 2021 Jan-Dec. Glob Reg Health Technol Assess. 2021. PMID: 36627866 Free PMC article. Italian.
-
Costs attributable to criminal justice involvement in injuries: a systematic review.Inj Prev. 2023 Feb;29(1):91-100. doi: 10.1136/ip-2022-044756. Epub 2022 Dec 5. Inj Prev. 2023. PMID: 36600522 Free PMC article.
-
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. MMWR Recomm Rep. 2022. PMID: 36327391 Free PMC article.
-
Effect of Perioperative Opioid Use on Patients Undergoing Hip Arthroscopy.Orthop J Sports Med. 2022 Mar 7;10(3):23259671221077933. doi: 10.1177/23259671221077933. eCollection 2022 Mar. Orthop J Sports Med. 2022. PMID: 35284588 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
